Cargando…
Stimulation of DC-CIK with PADI4 Protein Can Significantly Elevate the Therapeutic Efficiency in Esophageal Cancer
BACKGROUND: PADI4 has extensive expression in many tumors. This study applied PADI4 as a tumor marker to stimulate DC- (dendritic cell-) CIK (cytokine-induced killer), an immunotherapy approach. METHODS: A PADI4 expression plasmid was transfected into EC-originating ECA-109 cells. PADI4 gene was als...
Autores principales: | Liu, Chunyan, Zheng, Yingying, Tang, Junyi, Wang, Dawei, Ma, Zhenshen, Li, Shutong, Chang, Xiaotian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421725/ https://www.ncbi.nlm.nih.gov/pubmed/30944835 http://dx.doi.org/10.1155/2019/6587570 |
Ejemplares similares
-
PADI4 stimulates esophageal squamous cell carcinoma tumor growth and up‐regulates CA9 expression
por: Liu, Chunyan, et al.
Publicado: (2018) -
PADI2 Is Significantly Associated with Rheumatoid Arthritis
por: Chang, Xiaotian, et al.
Publicado: (2013) -
PADI4 and tumourigenesis
por: Chang, Xiaotian, et al.
Publicado: (2010) -
Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer
por: Liu, Guiyuan, et al.
Publicado: (2022) -
Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody
por: Wang, Yan, et al.
Publicado: (2023)